Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

NCT04614246 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

215

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated by Sponsor

Conditions

Endometriosis

Interventions

DRUG: BAY1817080
DRUG: Elagolix
DRUG: Placebo

Sponsor

Bayer